project id: TCGA-ESCA; case submitter id: TCGA-LN-A49N; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.82; age at index: 50; days to birth: -18503; ethnicity: not hispanic or latino; gender: male; race: asian; vital status: Alive; year of birth: 1960; age at diagnosis: 18503; ajcc clinical m: M0; ajcc clinical n: N1; ajcc clinical stage: Stage IIB; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 378.0; icd 10 code: C15.4; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Middle third of esophagus; synchronous malignancy: No; tissue or organ of origin: Middle third of esophagus; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: No; is ffpe: false; days to collection: 627; days to sample procurement: 0; initial weight: 300.0; portion submitter id: TCGA-LN-A49N-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 1.0; percent necrosis: 18.0; percent neutrophil infiltration: 1.0; percent normal cells: 12.0; percent stromal cells: 40.0; percent tumor cells: 30.0; percent tumor nuclei: 60.0;